Treatment with the hyaluronic Acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation. (Q51672726)

9 April 2018

title

Treatment with the hyaluronic Acid synthesis inhibitor 4-methylumbelliferone suppresses LPS-induced lung inflammation. (English)

1 reference

9 April 2018

0 references

Robert J McKallip

1

1 reference

9 April 2018

Hao Ban

series ordinal

2

1 reference

9 April 2018

Olga N Uchakina

series ordinal

3

1 reference

9 April 2018

publication date

1 June 2015

1 reference

9 April 2018

published in

Inflammation

1 reference

9 April 2018

volume

38

1 reference

9 April 2018

issue

3

1 reference

9 April 2018

page(s)

1250-1259

1 reference

9 April 2018

https://scigraph.springernature.com/pub.10.1007/s10753-014-0092-y

exact match

0 references

cites work

Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Incidence and outcomes of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Epidemiology and outcomes of acute lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Pharmacotherapy for acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Effects of acute ozone exposure on lung peak allergic inflammation of mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Role of hyaluronan and hyaluronan-binding proteins in human asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Quercetin inhibits IL-1β-induced inflammation, hyaluronan production and adipogenesis in orbital fibroblasts from Graves' orbitopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Hyaluronan fragments: an information-rich system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Different molecular weight hyaluronic acid effects on human macrophage interleukin 1β production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Low molecular weight hyaluronan activates cytosolic phospholipase A2α and eicosanoid production in monocytes and macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

High-molecular-weight hyaluronan is a novel inhibitor of pulmonary vascular leakiness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Oral administration of high molecular weight hyaluronan (900 kDa) controls immune system via Toll-like receptor 4 in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

The role of hyaluronic acid in SEB-induced acute lung inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Targeting hyaluronic acid production for the treatment of leukemia: treatment with 4-methylumbelliferone leads to induction of MAPK-mediated apoptosis in K562 leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

CD44 as a novel target for treatment of staphylococcal enterotoxin B-induced acute inflammatory lung injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Treatment with the hyaluronic acid synthesis inhibitor 4-methylumbelliferone suppresses SEB-induced lung inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Role of CD44 in activation-induced cell death: CD44-deficient mice exhibit enhanced T cell response to conventional and superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Animal models of sepsis and sepsis-induced kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Cytokine-mediated inflammation in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

4-methylumbelliferone, a hyaluronan synthase suppressor, enhances the anticancer activity of gemcitabine in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Differential effect of molecular mass hyaluronan on lipopolysaccharide-induced damage in chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Hyaluronan induces cell death in activated T cells through CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Development of a novel treatment for leukemia directed at tumor-associated mRNA splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

In vitro synthesis of hyaluronan by a single protein derived from mouse HAS1 gene and characterization of amino acid residues essential for the activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Regulation of lung injury and repair by Toll-like receptors and hyaluronan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Hyaluronan as an immune regulator in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Resolution of lung inflammation by CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10753-014-0092-Y

Simple method for quantitation of enhanced vascular permeability.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25537799

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25537799

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10753-014-0092-Y

1 reference

9 April 2018

PubMed ID

25537799

1 reference

9 April 2018